Microsofts Largest India Data Center on Track for Mid2026 Opening Japan China Trade Chiefs Hold First Bilateral Talks Since Escalating Trade Dispute April Jobs Report Preview Labor Market Resilience Amid Cooling Signals Planet Fitness Draws Investor Focus Amid Health and Fitness Sector Interest US REIT MA Shift PublictoPublic Consolidation Takes the Lead AlphaSense Highlights 10 Major Mergers and Acquisitions Shaping 2025 ORA Q1 2026 Earnings EPS Soars Past Estimates as Operational Efficiency Drives Strong Beat LIEN Q1 2026 Earnings Robust EPS Surprise of 2168 Highlights Strong Portfolio Performance Orange County Bancorp Inc OBT Q1 2026 Earnings Solid EPS Beat Amid Rising Deposit Costs CTXR Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss MFAO Q1 2026 Earnings Narrow Earnings Miss Reflects Stable mREIT Performance GRNT Q1 2026 Earnings Steep EPS Miss Despite Minor Stock Gain Murano Global Investments Warrants MRNOW Plunge Amid Thin Trading Key Levels to Watch STERIS STE Faces Modest Pullback as Shares Test Key Technical Zone FrontView REIT Inc FVR Slides 151 as Resistance Caps NearTerm Upside Quad Graphics QUAD Holds Near Support as Modest Gains Persist Ultra Clean Holdings UCTT Declines 468 as Semiconductor Equity Faces Renewed Pressure AIV Q3 2024 Earnings EPS Misses Estimates as Company Reports Wider Loss EVI Industries Q1 2026 Earnings EPS Miss Weighs on Shares Revenue Details Not Disclosed Metalla Royalty Streaming Q1 2026 Earnings EPS Misses Estimates but Stock Rises 545 on Strategic Progress TFX Q1 2026 Earnings EPS Surges Past Estimates Despite Market Headwinds UAA Q1 2026 Earnings EPS Miss Amid Strategic Restructuring Progress AGNCO Q1 2026 Earnings Preferred Shares Deliver EPS Beat Amid Stable Mortgage REIT Operations Salesforce Shares Decline on Disappointing Revenue Outlook Amid AI Disruption Concerns TIMB Q1 2026 Earnings EPS Misses Estimates as Operational Challenges Persist InMode INMD Pushes Higher Testing Resistance After a 16 Gain AXIA Energia AXIA Retreats from Resistance Support Levels Under Scrutiny Amylyx Pharmaceuticals AMLX Edges Higher Testing Key Resistance After Modest Gain Real Messenger Corporation RMSG Plunges Over 15 Key Support Level Under Siege Damora Therapeutics DMRA Gains 24 as Biotech Sector Finds Footing TriplePoint Venture Growth BDC TPVG Slips 21 as Pressure Mounts Near Key Support Sonoma Pharmaceuticals SNOA Edges Higher Testing Key Resistance at 113 Praxis Precision Medicines PRAX Edges Lower Following Recent Rally Key Support Tested